TrialDiabetes, obesity & metabolism2019

Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.